Cincinnati Magazine’s 10th annual Slice Night returns
100% of ticket proceeds support the University of Cincinnati Cancer Center
Cincinnati Magazine’s popular Slice Night returns to Yeatman's Cove for an evening of all-you-can-eat pizza for an incredible cause. The 10th annual Slice Night benefiting the University of Cincinnati Cancer Center is set for Wednesday, Sept. 20 from 5:30-8:30 p.m.
Slice Night is an outdoor event along the riverfront featuring pizza from ten popular Greater Cincinnati pizzerias with 100 percent of ticket proceeds benefiting cancer patients and care teams at the University of Cincinnati Cancer Center. This event truly is a pizza lover’s dream.
“We look forward to this fun, delicious, family-friendly event every year, as we get to showcase some of our city’s incredible local pizzerias while supporting a very worthy local cause,” said Ivy Bayer, publisher of Cincinnati Magazine. “Slice Night is a fun and delicious way to not only experience a wide variety of pizza styles and toppings, but you’ll also feel good about devouring countless slices as 100% of proceeds go directly to the important work of the UC Cancer Center, and the patients they care for.”
Guests will enjoy live music by the The Satin Smooth Project while strolling the riverfront and enjoying unlimited pizza samples from Cincinnati’s favorite local pizzerias. Fritsch from Q102 will serve as the official event emcee. Bonus menu items include pasta, flatbreads, dessert and snacks from notable vendors and brands. Beer, wine, soda and water will be available for purchase.
Participating pizzerias include:
|
|
The 10th annual Slice Night is Sept. 20.
“We are so very grateful to everyone joining the 10th annual Slice Night and supporting our mission at the University of Cincinnati Cancer Center to do all that we can to minimize the suffering and mortality associated with this disease in our community,” said William Barrett, MD, co-director of the Cancer Center and professor and chair of the UC Department of Radiation Oncology. “No one wants the diagnosis of cancer, but if one has to face this adversary, we want Greater Cincinnati to be the very best place in the world to be.”
Cincinnati Magazine’s Slice events have raised more than $270,000 for the University of Cincinnati Cancer Center since they began in 2014.
General admission tickets may be purchased online in advance for $20, or $25 at the door. Children 10 and younger are $10. VIP tickets are $75 and include a parking pass, access to a VIP tent with a private open bar, covered seating, additional food options and gourmet desserts.
All tickets also include a complimentary one-year subscription to Cincinnati Magazine.
Visit cincinnatimagazine.com/slice to learn more and purchase tickets.
Slice Night 2023 is made possible by the generous support of Western & Southern Financial Group (presenting sponsor), MadTree Brewing (sustainability sponsor), Belgian Boys, Butterball, Chinet, McCormick, Kendall Jackson, Takis, Rao's, Home Chef, Pepcid, Garnish Catering, Veroni and Performance Foods.
Featured image at top: Provided
Candice Terrell
For the UC Foundation
Candice Terrell is a Cincinnati writer.
Tags
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.